Developing a novel intervention to support clinicians to identify people at risk of rheumatoid arthritis in primary care through targeted anti-CCP testing – what are the key considerations?

Talk Code: 
3F.5
Presenter: 
Dr Heidi J Siddle
Twitter: 
Co-authors: 
Anna M Anderson, Stephen H Bradley, Caroline A Flurey, Suzanne H Richards
Author institutions: 
University of Leeds, University of the West of England Bristol

Problem

The early symptoms of rheumatoid arthritis (RA) are often non-specific. Correspondingly, delays in identifying RA in primary care are common. Anti-cyclic citrullinated peptide (anti-CCP) testing of people who present to primary care with new-onset, non-specific musculoskeletal symptoms could help address this, as around one third who test positive for anti-CCP develop RA within a year. Inappropriate anti-CCP testing could have negative effects, so targeting anti-CCP testing is vital. This project aims to develop a novel intervention, the ‘Improving iDEntification of rheumatoid ArthritiS (IDEAS) in primary care’ (IDEAS-PC) model, to support clinicians to identify people at risk of RA in primary care through targeted anti-CCP testing.

Approach

This project is a qualitative intervention development study with three sequential phases.

Phase 1 (completed)

• Semi-structured interviews with eight General Practitioners (GPs) and eight Musculoskeletal First Contact Practitioners (FCPs).

• Data were analysed using the framework method and Behaviour Change Wheel to develop themes and a list of candidate components for the IDEAS-PC model.

Phase 2 (completed)

• Two workshops with three GPs and five FCPs.

• Data were analysed using content analysis to create a refined and prioritised list of components and inform the creation of an IDEAS-PC model prototype.

Phase 3 (ongoing)

• Think-aloud interviews with six to twelve primary care clinicians to test the IDEAS-PC model prototype.

• Data will be analysed using a ‘Table of changes’ to enable the prototype to be iteratively refined.

A Project Advisory Group, involving Patient and Public Involvement representatives and professionals, are overseeing the study and contributing to the IDEAS-PC model development.

Findings

Four intersecting themes were developed from the Phase 1 findings.

‘Variations in current practice’ is an overarching theme that highlights how clinicians’ anti-CCP test requesting practices and other aspects of current RA diagnostic pathways vary widely. These variations appeared to underpin participants’ differing views of the IDEAS-PC model.

The following themes relate to additional factors that are likely to influence whether clinicians will use the IDEAS-PC model:

• ‘Considering interpersonal influences across the whole healthcare system’

• ‘Balancing potential benefits versus risks’

• ‘Promoting access to and usability of the IDEAS-PC model’

The Phase 1 findings were used to develop a list of nine candidate components for the IDEAS-PC model. During the Phase 2 workshops four components were prioritised for inclusion in the IDEAS-PC model:

• Decision tool

• Guidance on using the decision tool and associated actions

• Evidence for the decision tool

• Patient education resources

Consequences

Addressing unwarranted variations in primary care clinicians’ anti-CCP test requesting practices is a priority.

The IDEAS-PC model could be valuable for guiding targeted anti-CCP testing in primary care, but whether it is used in practice will depend on key considerations such as whether clinicians believe its benefits outweigh its risks and its usability.

Submitted by: 
Heidi Siddle
Funding acknowledgement: 
Dr Heidi Siddle, Senior Clinical Lecturer, ICA-SCL-2018-04-ST2-004, is funded by Health Education England (HEE) / NIHR for this research project. Dr Anna Anderson is funded by HEE/NIHR as a Research Fellow on the same project. The views expressed in this presentation are those of the author(s) and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care.